Relevant articles were recognized using keywords such as natural products, bioactive components, airway inflammation, asthma, COPD, and acute lung injury, along with specific experimental models (e.g., OVA-induced asthma, PM-induced airway inflammation, CS-induced COPD, crystalline silica-induced lung injury)
However, the reconstituted solution must be used within 28 days, and three weekly doses spans 21 days, well within that window
As shown in Figure 4A, BPC-157 (1 g/mL10 g/mL) was found to significantly increase the proliferation of HUVECs in a concentration-dependent manner after 48 hours of treatment
Demand is likely to rise as obesity treatment and cardiovascular risk reduction widen the eligible patient pool